Renal replacement therapy review: Past, present and future

Organogenesis

Volumn 7, Issue 1, 2011, Pages 2-12

  Fleming, Geoffrey M ^a  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

Author keywords

AUTHOR: please provide 5 7

Indexed keywords

CELLULOSE; POLYACRYLONITRILE; POLYSULFONE; POLYVINYLCHLORIDE;

ACIDOSIS; ACUTE KIDNEY FAILURE; ARTIFICIAL KIDNEY; CHRONIC KIDNEY FAILURE; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; COST OF ILLNESS; DIALYSATE; DIALYSIS CATHETER; DIALYSIS EQUIPMENT AND SUPPLIES; DIALYSIS PUMP; EXTENDED DAILY DIALYSIS; EXTRACORPOREAL OXYGENATION; HEMODIALYSIS; HUMAN; HYPERKALEMIA; MICROPROCESSOR; NONHUMAN; PERITONEAL DIALYSIS; RENAL REPLACEMENT THERAPY; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ULTRAFILTRATION;

HUMANS; KIDNEY, ARTIFICIAL; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY;

EID: 79952370958     PISSN: 15476278     EISSN: 15558592     Source Type: Journal    
DOI: 10.4161/org.7.1.13997     Document Type: Review

References (157)

1. Abel JJ, Rowntree LG, Turner BB. On the removal of diffusible substances from the circulating blood by means of dialysis. In McCarthy LJ. Plasmapheresis-The Indiana Connection. Transfusion Sciences 1990; 11:161-77.
2. Kolff WJ, Berk HTHJ. The artificial Kidney: A dialyser with a great area. Acta Med Scand 1944; 121-34.
3. Teschan PE. Acute renal failure during the Korean war. Renal Failure 1992; 14:237-9.
4. Alwall N, Norbit L, Steins AM. Clinical extracorporeal dialysis of blood with artificial kidney. Lancet 1948; 1:60-2.
5. Putnam TJ. The living peritoneum as a dialyzing membrane. Am J Physiol - Legacy Content 1923; 63:548-65.
6. Fine J, Frank HA, Seligman AM. The treatment of acute renal failure by peritoneal irrigation. Annals of Surgery 1946; 124:857-76.
7. Palmer RH, Quinton WE. Prolonged peritoneal dialysis for chronic renal failure. Lancet 1964; 1:700-2.
8. Tenckhoff J, Schechter HA. Bacteriologically safe peritoneal access device. Trans Am Soc Artif Intern Organs 1968; 14:181-7.
9. Scribner BH, Caner JE, Buri R, Quinton W. The technique of continuous hemodialysis. Trans Am Soc Artif Intern Organs 1960; 6:88-103.
10. Pendras JP, Cole JJ, Tu WH, Scribner BH. Improved technique of continuous flow hemodialysis. Trans Am Soc Artif Intern Organs 1961; 7:27-36.
11. Bartlett RH, Bosch J, Geronemus R, Pagnini E, Ronco C, Swartz R. Continous arteriovenous emofiltration for acute renal failure. ASAIO Trans 1988; 34:67-77. (Pubitemid 18094599)
12. Mault JR, Dechert RE, Lees P, Swartz R, Port JK, Bartlett RH. Continuous arteriovenous filtration: an effective treatment for surgical acute renal failure. Surgery 1987; 101:478-84. (Pubitemid 17050429)
13. Heiss KF, Pettite B, Hirschl RB, Cilley RE, Chapman R, Bartlet RH. Renal insufficiency and volume over-load in neonatal ECMO managed by continuous ultrafiltration. ASAIO Trans 1987;33557-60.
14. Canaud B, Garred LJ, Christol JP, Aubas S, Beraud JJ, Mion C. Pump assisted continuous venovenous hemofiltration for treating acute uremia. Kidney Int 1988; 24:154-6.
15. Yorgin PD, Krensky AM, Tune BM. Continuous venovenous hemofiltration. Pediatr Nephrol 1990; 4:640-2.
16. K/DOQI Clinical Practice Guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kid Dis 2002; 39:1-266.
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130:461-70. (Pubitemid 29135798)
18. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
19. Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A. Pediatrics 1976; 58:259-63.
20. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, ADQI Workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care Med 2004; 8:204-12.
21. Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007; 71:1028-35. (Pubitemid 46741996)
22. Chantler C, Garnett ES, Parsons V, Veall N. Glomerular filtration rate measurement in man by the single injection method using 51-Cr-EDTA. Clin Sci 1969; 37:169-80.
23. Shermesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28:830-8. (Pubitemid 16156326)
24. Moore AE, Park-Holohan SJ, Blake GM, Fogelman I. Conventional measurements of GFR using 51-Cr-EDTA overestimate true renal clearance by 10 percent. Eur J Nucl Med Mol Imaging 2003; 30:4-8. (Pubitemid 36692886)
25. Proulx NL, Akbari A, Garg AX, Rostom A, Jaffey J, Clark HD. Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis. Nephrol Dial Transplant 2005; 20:1617-22. (Pubitemid 41418585)
26. Trof RJ, Di Maggio F, Leemreis J, Groeneveld ABJ. Biomarkers of acute renal injury and renal failure. Shock 2006; 26:245-53.
27. Edelstein CL. Biomarkers of acute kidney injury. Adv Chronic Kidney Dis 2008; 15:222-34. (Pubitemid 351822595)
28. Schuller D, Mitchell JP, Calandrino FS, Schuster DP. Fluid balance during pulmonary edema. Is fluid gain a marker or a cause of poor outcome? Chest 1991; 100:1068-75.
29. Alsous F, Khamlees M, DeGirolamo A, Amoateng- Adjepong Y, Manthous CA. Negative fluid balance predicts survival in patients with septic shock. Chest 2000; 117:1749-54. (Pubitemid 30413373)
30. Goldstein SL, Currier H, Graf Cd, Cosio CC, Brewer ED, Sachdeva R. Outcome in children receiving Continuous Venovenous Hemofiltration. Pediatrics 2001; 107:1309-12. (Pubitemid 32525207)
31. Foland JA, Fortenberry JD, Warshaw BL, Pettignano R, Merritt RK, Heard ML, et al. Fluid overload before continuous hemofiltration and survival in critically ill children: A retrospective analysis. Crit Care Med 2004; 32:1771-6. (Pubitemid 39050531)
32. Michael M, Kuehnle I, Goldstein SL. Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatr Nephrol 2004; 19:91-5. (Pubitemid 38088257)
33. Gillespie RS, Seidel K, Symons JM. Effect of fluid overload and dose of replacement fluid on survival in hemofiltration. Pediatr Nephrol 2004; 19:1394-9. (Pubitemid 39530550)
34. Goldstein SL, Somers MJG, Baum MA, Symons JM, Brophy PD, Blowey D, et al. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney International 2005; 67:653-8. (Pubitemid 40139857)
35. Gomez A, Wang R, Unruh H, Light RB, Bose D, Chau T, et al. Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 1990; 73:671-85.
36. Grootendorst AF, Van Bommel EF, van der Hoven B, van Leengoed LA, van Osta AL. High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992; 18:235-40.
37. Grootendorst AF, van Bommel EFH, van Leengoed LAMG, van Zanten ARH, Huipen HJC, Groeneveld ABJ. Infustion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J of Crit Care 1993; 8:161-9. (Pubitemid 23275999)
38. Ronco C, Inguaggiato P, D'Intini V, Cole L, Bellomo R, Poulin S, et al. The role of extracorporeal therapies in sepsis. J Nephrol 2003; 16:34-41.
39. Heering P, Morgera S, Schmitz FJ, Schmitz G, Willers R, Schultheiss HP, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Int Care Med 1997; 23:288-96. (Pubitemid 27129994)
40. Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady JJ, Pinsky MR. Diffusive vs. convective therapy: Effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med 1998; 26:1995-2000. (Pubitemid 29016680)
41. Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000; 28:3581-7.
42. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet 2000; 356:26-30. (Pubitemid 30416991)
43. Cole L, Bellomo R, Hart G, Journois D, Davenport P, Tipping P, et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002; 30:100-6. (Pubitemid 34112184)
44. Ronco C, Ricci Z, Bellomo R. Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role of continuous venovenous haemofiltration. Curr Opin Nephrol Hypertens 2001; 10:755-61. (Pubitemid 33043669)
45. Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: A randomized controlled trial. Crit Care Med 2009; 37:803-10.
46. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327.
47. Brierly J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine 2009; 37:666-88.
48. Otsuki M, Hirota M, Arata S, Koizumi M, Kawa S, Kamisawa T, et al. Consensus of primary care in acute pancreatitis in Japan. World J Gastroenterol 2006; 12:3314-23. (Pubitemid 43933774)
49. Alfred HJ, Graff LG, Cohen AJ, Shuster A. Treatment of Renal Failure. In Rose BD Ed. Pathophysiology of renal disease. McGraw-Hill, New York 1981; 475-575.
50. Nguen MK, Kurtz I. Determinants of plasma water sodium concentrations as reflected in the Edelman equation: role of osmotic and Gibbs-Donnan equilibrium. Am J Physiol Renal Physiol 2004; 286:828-37.
51. Grassman A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 2005; 20:2587-93. (Pubitemid 41672250)
52. Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. Kidney) investigators. Int Care Med 2007; 33:1563-70.
53. Gatward JJ, Gibbon GJ, Wrathall G, Padkin A. Renal replacement therapy for acute renal failure: a survey of practice in adult intensive care units in the United Kingdom. Aneaesthesia 2008; 63:959-66.
54. Jha V. Periotoneal dialysis in India: current status and challenges. Perit Dial Int 2008; 28:36-41.
55. Yu AWY, Chau KF, Ho YW, Li PKT. Development of the "Peritoneal Dialysis First" model in Hong Kong. Perit Dial Int 2007; 27:53-5.
56. Li PK, Lui SL, Leung CB, Yu AW, Lee E, Just PM, et al. Increased utilization of peritoneal dialysis to cope with mounting demand for renal replacement therapy - Perspectives from Asian countries. Perit Dial Int 2007; 27:59-61.
57. Morelli S, Ricci Z, Di Chiara L, Stazi GV, Polito A, Vitale V, et al. Renal replacement therapy in neonates with congenital heart disease. Contrib Nephrol 2007; 156:428-33.
58. Pederson KR, Hjortdal VE, Christensen S, Pedersen J, Hjortholm K, Larsen SH, et al. Clinical outcome in children with acute renal failure treated with peritoneal dialysis after surgery for congenital heart disease. Kidney Int Supp 2008; 108:81-6.
59. Ahmad M, Robert R, Bargman JM, Oreopoulos D. Advantages of peritoneal dialysis in comparison to hemodialysis, in cardiac allograft recipients with end stage renal disease. Int Urol Nephrol 2008; 40:1083-7.
60. Warady BA, Bunchman TA. Dialysis therapy for children with acute renal failure: survey results. Pediatr Nephrol 2000; 15:11-3.
61. Strazdins V, Watson AR, Harvey B. European Pediatric Peritoneal Dialysis Working Group. Renal replacement therapy for acute renal failure in children: European Guidelines. Pediatr Nephrol 2004; 19:199-207.
62. Ronco C, Bellomo R. Dialysis in intensive care unit patients with acute kidney injury; continuous therapy is superior. Clin J Am Soc Nephrol 2007; 2:597-600.
63. Mehta RL, McDonald B, Gabbai FB, Pahl M, Pascual MT, Farkas A, et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney International 2001; 60:1154-63. (Pubitemid 34207769)
64. Kellum JA, Angus DC, Johnson JP, Leblanc M, Griffin M, Ramakrishnan N, et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Int Care Med 2002; 28:29-37. (Pubitemid 34118972)
65. Tonelli M, Manns B, Feller-Koopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 2002; 40:875-85. (Pubitemid 35265466)
66. Vinsonneau C, Camus C, Combes A, Costa de Beauregard MA, Klouche K, Boulain T, et al. Continuous venovenous hemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: A Multicenter randomized trial. Lancet 2006; 29:379-85. (Pubitemid 44108121)
67. VA/NIH Acute Renal Failure Trial Network. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, et al. Intensity of renal support in critically ill patients with acute kidney injury. NEJM 2008; 359:7-20.
68. Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993; 21:328-38. (Pubitemid 23097026)
69. Augustine JJ, Sandy D, Seifert TH, Paganini EP. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 2004; 44:1000-7. (Pubitemid 39556479)
70. Kielstein JT, Kretschmer U, Ernst T, Hafer C, Bahr MJ, Haller H, et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: A randomized controlled study. Am J Kidney Dis 2004; 43:342-9. (Pubitemid 38146333)
71. Symons JM, Brophy PD, Gregory MJ, McAfee N, Somers MJ, Bunchman TE, et al. Continuous renal replacement therapy in children up to 10 kg. Am J Kidney Dis 2003; 41:984-9. (Pubitemid 36532132)
72. Rauf AA, Long KH, Gajic O, Anderson SS, Swaminathan L, Albright RC. Renal replacement therapy for acute renal failure in intensive care unit: An observational outcomes analysis. J Int Care Med 2008; 23:195-203. (Pubitemid 351667151)
73. Vitale C, Bagnis C, Marangella M, Belloni G, Lupo M, Spina G, et al. Cost analysis of blood purification in intensive care units: Continuous versus intermittent hemodiafiltration. J Nephrol 2003; 16:572-9. (Pubitemid 38120468)
74. Manns B, Doig CJ, Lee H, Dean S, Tonelli M, Johnson D, et al. Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med 2003; 31:449-55. (Pubitemid 36232939)
75. Just PM, Riella MC, Tschosik EA, Noe LL, Bhattacharyya SK, de Charro F. Economic evaluations of dialysis treatment modalities. Health Policy 2008; 86:163-80.
76. Golper TA. Hybrid renal replacement therapies for critically ill patients; in Ronco C, Bellomo R, Brendolan A, Eds: Sepsis, Kidney and Multiple Organ Dysfunction. Contrib Nephrol Basel, Karger 2004; 144:278-83.
77. Berbece AN, Richardson RMA. Sustained low-efficiency dialysis in the ICU: Cost, anticoagulation and solute removal. Kidney Int 2006; 70:963-8. (Pubitemid 44285975)
78. Ma TM, Walker RE, Eggleton K, Marshall MR. Cost comparison between sustained low efficiency daily dialysis/diafiltration (SLEDD) and continuous renal replacment therapy (CRRT) for ICU patients with ARF. Nephrology 2002; 7:54.
79. National Kidney Foundation: KDOQI Clinical Practice Guidelines for hemodialysis adequacy 2000. Am J Kidney Dis 2001; 37:7-64.
80. National Kidney Foundation: KDOQI Clinical Practice Guidelines for peritoneal dialysis adequacy, Update 2006; Am J Kidney Dis 2006; 48:91-7.
81. Clark WR, Mueller BA, Kraus MA, Macias WL. Extracorporeal therapy requirements for patients with acute renal failure. J Am Soc Nephrol 1997; 8:804-12. (Pubitemid 27493595)
82. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccini P, et al. Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet 2000; 356:26-30. (Pubitemid 30416991)
83. Bouman CS, Oudemans Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective randomized trial. Crit Care Med 2002; 30:2205-11. (Pubitemid 35191568)
84. Vesconi S, Cruz D, Fumagalli R, Kindgen-Milles D, Moni G, Marinho A, et al. Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care 2009; 13:57.
85. Ricci Z, Ronco C. Dose and efficiency of renal replacement therapy: Continuous renal replacement therapy versus intermittent hemodialysis versus slow extended daily dialysis. Crit Care Med 2008; 36:229-37.
86. Venkataraman R, Kellum JA, Palevsky P. Dosing patterns for CRRT at a large academic medical center in the United States. J Crit Care 2002; 17:246-50. (Pubitemid 35447400)
87. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Continuous is not continuous: the incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 2003; 29:575-8.
88. Tolwani A, Wheeler TS, Wille KM. Sustained low-efficiency dialysis; in Ronco C, Bellomo R, Kellum A, Eds: Acute Kidney Injury. Contrib Nephrol Basel, Karger 2007; 156:320-4.
89. Kumar VA, Craig M, Depner T, Yeu JY. Extended daily dialysis: A new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis 2000; 36:294-300. (Pubitemid 30485837)
90. Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK. Sustained low-efficienc dialysis for critically ill patients requiring renal replacement therapy. Kidney Int 2001; 60:777-85. (Pubitemid 32678922)
91. Marshall MR, Tianmin M, Galer D, Rankin APN, Wiliams AB. Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy. Nephrol Dial Transplant 2004; 19:877-84. (Pubitemid 38455659)
92. th Annual International Conference on Continuous Renal Replacement Therapies, February 25-28 2009, San Diego California.
93. Ronco C, LaGreca G, Eds. Hemodialysis Technology. Contributions to Nephrology 2002; 137:1-438.
94. Morgera S, Heering P, Szentandrasi T, Manassa E, Heintzen M, Willers R, et al. Comparison of a lactate-versus acetate-based hemofiltration replacement fluid in patients with acute renal failure. Ren Fail 1997; 19:155-64. (Pubitemid 27082313)
95. Tan HK, Uchino S, Bellomo R. The acid-base effects of continuous hemofiltration with lactate or bicarbonate buffered replacement fluids. Int J Artif Organs 2003; 26:477-83. (Pubitemid 36916697)
96. Heering P, Ivens K, Thumer O, Morgera S, Heintzen M, Passlick-Deetjen J, et al. The use of different buffers during continuous hemofiltration in critically ill patients with acute renal failure. Int Care Med 1999; 25:1244-51.
97. Wendon J, Smithies M, Sheppard M, Bullen K, Tinker J, BIhari D. Continuous high volume venous-venous haemofiltration in acute renal failure. In Care Med 1989; 15:358-63. (Pubitemid 19236051)
98. Thomas AN, Guy JM, Kishen R, Geraghty IF, Bowles BJM, Vadgama P. Comparison of lactate and bicarbonate buffered haemodifltration fluids: use in critically ill patients. Nephrol Dial Transplant 2000; 58:1751-7.
99. Barenbrock M, Hausberg M, Matzkies F, de la Motte S, Schaeffer RM. Effects of bicarbonate and lactate buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney Int 2000; 58:1751-7.
100. McLean AG, Davenport A, Cox D, Sweny P. Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver disease. Kidney Int 2000; 58:1765-77.
101. Zimmerman D, Cotman P, Ting R, Karanicolas S, Tobe SW. Continuous veno-venous haemodialysis with a novel bicarbonate dialysis solution: prospective cross-over comparison with a lactate buffered solution. Nephrol Dial Transp 1999; 14:2387-91. (Pubitemid 29462476)
102. Hoenich NA, Levin R, Ronco C. How do changes in water quality and dialysate composition affect clinical outcomes. Blood Purif 2009; 27:11-5.
103. Hoenich N, Thijssen S, Kitzler T, Levin R, Ronco C. Impact of water quality and dialysis fluid composition on dialysis practice. Blood Purif 2008; 26:6-11.
104. Sharma R, Rosner MH. Glucose in the dialysis: Historical perspective and possible implications. Hemodialysis Int 2008; 12:221-6. (Pubitemid 351494275)
105. Vigano SM, Di Filippo S, Manzoni C, Locatelli F. Dialysate Composition. In Ronco C, Cruz DN, Eds: Hemodialysis-From Basic Research to Clinical Trial. Contrib Nephrol. Basel, Karger 2008; 161:7-11.
106. Palmer B. Individualizing the dialysate in the hmodialysis patient. Seminars in Dialysis 2001; 14:41-9.
107. Aucella F, Di Paulo S, Gesualdo L. Dialysate and replacement fluid composition for CRRT. In Ronco C, Bellomo R, Kellum JA, Eds: Acute kidney injury. Contrib Nephrol. Basel, Karger 2007; 156:287-96.
108. Hoenich NA, Levin R. The implications of water quality in hemodialysis. Semin Dial 2003; 16:492-7. (Pubitemid 37550131)
109. Lonnermann G. When good water goes bad: How it happens, clinical consequences and possible solution. Blood Purif 2004; 22:124-9.
110. Pontoriero G, Pozzoni P, Andrulli S, Locatelli F. The quality of dialysis water. Nephrol Dial Transplant 2003; 18:21-5.
111. th Ed 2002.
112. Masakane I. Review: Clinical usefulness of ultrapure dialysate - Recent evidence and perspectives. Therapeutic Apheresis and Dialysis 2006; 10:348-54. (Pubitemid 44154765)
113. Hoenich NA, Levin. Water treatment for dialysis: Technology and clinical implications. In Ronco C, Cruz DN, Eds. Hemodialysis-From basic research to clinical trials. Contrib Nephrol. Basel, Karger 2008; 161:1-6.
114. International Organization for Standardization. ISO 26722, 2009.
115. International Organization for Standardization. ISO 13958, 2009.
116. International Organization for Standardization. ISO 13959, 2009.
117. Pass T, Wright A, Sharp B, Harding GB. Culuture of dialysis fluids on nutrient rich media for short periods at elevated temperature underestimate microbiological contamination. Blood Purif 1996; 14:136-45. (Pubitemid 26079580)
118. Jones MR. Intraperotoneal amino acids: A therapy whose time has come? Perit Dial Int 1995; 15:67-74.
119. Jones MR, Gehr TW, Burkart JM, Hamburger RJ, Kraus AP Jr, Piraino BM, et al. Replacement of amino acid and protein losses with 1.1% amino acid peritoneal dialysis solution. Perit Dial Int 1998; 18:210-6. (Pubitemid 28221305)
120. Li FK, Chan LY, Woo J, Ho SK, Lo WK, Lai KN, et al. A 3 year prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am J Kidney Dis 2003; 42:173-83. (Pubitemid 36807667)
121. Chhabra D, Nash K. Icodextrin: an alternative peritoneal dialysis fluid. Expert Opin Drug Metab Toxcol 2008; 4:1455-64.
122. Wolfson M, Piraino B, Hamburger JR, Morton AR. Icodextrin study group. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 2002; 40:1055-65. (Pubitemid 35265487)
123. Sicca S, Maggiore U. Beneficial effect of icodextrin on the hypertriglyceridemia of CAPD patients. Perit Dial Int 2002; 22:727-9. (Pubitemid 36131506)
124. Amici G, Orrasch M, DaRin G, Bocci C. Hyperinsulinism reduction associated with icodextran treatment in CAPD patients. Adv Perit Dial 2001; 17:80-3.
125. Raja R, Kramer M, Goldstein S, Caruana R, Lerner A. Comparison of continuous arteriovenous hemofiltration and continuous areriovenous dialysis in critically ill patients. Trans Am Soc Artif Intern Organs 1986; 32:435-6.
126. Alonso A, Lau J, Jaber BL. Biocompatible hemodialysis membranes for acute renal failure. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD005283. DOI:10.1002/14651858.CD005283. pub2.
127. Vigano SM, Di Filippo S, Manzoni C, Locatelli F. Membrane Characteristics. In Ronco C, Cruz DN, Eds. Hemodialysis-From basic research to clinical trials. Contrib Nephrol. Basel, Karger 2008; 161:162-7.
128. Twardoski ZJ. Dialyzer Reuse-Part I: Historical perspecive. Semin Dial 2006; 19:41-53.
129. Twardowski ZJ. Dialyzer Reuse-Part II: Advantages and Disadvantages. Semin Dial 2006; 19:217-26.
130. Lacson E, Lazarus JM. Dialyzer best practice: Single use or reuse? Semin Dial 2006; 19:120-8.
131. Robinson BM, Feldman HI. Dialyzer reuse and patient outcomes: What do we know now? Semin Dial 2005; 18:175-9.
132. National Kidney Foundation report on dialyzer reuse. Task force on reuse of dialyzers, council on dialysis, National Kidney Foundation. Am J Kidney Dis 1997; 30:859-71.
133. Chuang FR, Lee CH, Chang HW, Lee CN, Chen TC. A quality and cost-benefit analysis of dialyzer reuse in hemodialysis patients. Renal Failure 2008; 30:521-6.
134. Kutsogiannis DJ, Mayers I, Chin WDN, Gibney RTN. Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kid Dis 2000; 35:802-11. (Pubitemid 30238190)
135. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous hemofiltration: a prospective randomized study. Int Care Med 2004; 30:260-5. (Pubitemid 38253417)
136. Brophy PD, Somers MJG, Baum MA, Symons JM, McAfee N, Fortenberry JD, et al. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant 2005; 20:1416-21. (Pubitemid 41430615)
137. Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM. A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol 2006; 1:79-87.
138. Apsner R, Buchmayer H, Lang T, Unver B, Speiser W, Sunder-Plassmann G, et al. Simplified citrate anticoagulation for High-flux hemodialysis. Am J Kid Dis 2001; 38:979-87. (Pubitemid 33022175)
139. Marshall MR, Ma TM, Eggleton K, Ferencz A. Regional citrate anticoagulation during simulated treatments of sustained low efficiency diafiltration. Nephrology 2003; 8:302-10. (Pubitemid 38037275)
140. Clark JA, Schulman G, Golper TA. Safety and efficacy of regional citrate anticoagulation during 8 hour sustained low-efficiency dialysis. Clin J Am Soc Nephrol 2008; 3:736-42.
141. Fleming GM, Walters S, Mottes TA, Brophy PD. Hypocalcemic citrate toxicity(HCCT) associated with regional citrate anticoagulation during pediatric CRRT. {Abstract} Blood Purif 2009; 27:271-305.
142. Lewin AJ, Greenbaum MA, Gordon A, Maxwell MH. Current status of the clinical application of the Redy R dialysate delivery system. Proc Clin Dial Transplant Forum 1972; 2:52-6.
143. Nielsen B. The REDY system. Experiments and experiences. Introduction. Scand J Urol Nephrol 1976; 30:5-7.
144. Fuchs C, Dorn D, Rieger J, van Doorn AW, Striebel JP, Scheler F. Capabilities of the Redy cartridge for regeneration of hemofiltrate. Artif Organs 1979; 3:279-80. (Pubitemid 10250585)
145. Ash SR. The Allient Dialysis System. Semin Dial 2004; 17:164-6. (Pubitemid 38560994)
146. McGill RL, Bakos JR, Ko T, Sandroni SE, Marcus RJ. Sorbent hemodialysis: Clinical experience with new sorbent cartridges and hemodialyzers. ASAIO Journal 2008; 54:618-21.
147. Ronco C, Fecondini L. The Vicenza Wearable Artificial Kidney for Peritoneal Dialysis (ViWAK PD). Blood Purif 2007; 25:383-8. (Pubitemid 47450571)
148. Davenport A, Gura V, Ronco C, Beizai M, Ezon C, Rambod E. A wearable haemodialysis device for patients with end-stage renal failure: a pilot study. Lancet 2007; 370:2005-10. (Pubitemid 350236337)
149. Gura V, Macy AS, Beizai M, Ezon C, Golper TA. Technical breatkthroughs in the Wearable Artificial Kidney (WAK). CJASN 2009; 4:1441-8.
150. Humes HD, MacKay SM, Funke AJ, Buffington DA. Tissue engineering of a bioartificial renal tubule assist device: In vitro transport and metabolic characteristics. Kidney Int 1999; 55:2502-14.
151. Humes HD, Weitzel WF, Bartlett RH, Swaniker FC, Paganini EP, Luderer JR, et al. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 2004; 66:1578-88. (Pubitemid 39298393)
152. Saito A. Research into the development of a wearable bioartificial kidney with a continous hemofilter and a bioartificial tubule device using tubular epithelial cells. Artif Organs 2004; 28:58-63. (Pubitemid 38234246)
153. Saito A, Aung T, Sekiguchi K, Sato Y. Present status and perspective of the development of a bioartificial kidney for chronic renal failure patients. Therapeutic Apher Dial 2006; 10:342-7. (Pubitemid 44154764)
154. Fissell WH, Fleischman AJ, Humes HD, Roy S. Development of continuous implantable renal replacement: past and future. Translational Res 2007; 150:327-36. (Pubitemid 350101438)
155. Tiranathanagul K, Eiam-Ong S, Humes HD. The future of renal support: High-flux dialysis to bioartificial kidneys. Crit Care Clin 2005; 21:379-94. (Pubitemid 40386762)
156. Tumlin J, Wali R, Williams W, Murray P, Tolwani AJ, Vinnikova AK, et al. Efficacy and safety of renal tubule cell therapy for acute renal failure. JASN 2008; 19:1034-40.
157. Nissenson AR, Rionco C, Pergamit G, Edelstein M, Watts R. The human nephron filter: Toward a continuously functioning, implantable artificial nephron system. Blood Purif 2005; 23:269-74. (Pubitemid 41327797)